A major risk factor for breast cancer is carrying a harmful mutation in the BRCA1 or BRCA2 genes. Finding out whether or not a BRCA gene alteration is harmful hasn’t been all that easy, though. That could be changing.

“I hurt, ache, swell, pain, shuffle, have significant join pain, have cognitive issues, and feel like I’m 80 when I’m mid-50’s. But I’m also so afraid of the breast cancer that I shuffle alongside of everyone, like you do.” Those are the words of a breast cancer survivor talking on a social media channel.

The biggest risk factor for bladder cancer is smoking. That’s well known. Now, researchers have discovered that how much a person smokes has an impact on the course of the disease.

To find out if a lung cancer prevention drug is effective, scientists may follow thousands of patients for more than a decade. A recent discovery of a molecular response may significantly shorten these trials.

A PSA test is a common way to screen for prostate cancer. While a single PSA reading may signal prostate trouble, repeated measurements of PSA may offer a more precise means of detection.

There’s an app for just about everything these days. But when it comes to diagnosing any type of cancer, nothing beats a real doctor. Seriously, go to a real doctor.

When chemotherapy is prescribed for colorectal cancer, doctors don’t always know if it will work for an individual treatment. A new tool might help predict success.

Cancer outcomes are not black and white. There are constantly shifting variables that can change the course of disease. Scientists have scratched beneath the surface of shifts in ovarian cancer cells.

Unless a child is involved, age usually isn’t considered when prescribing cancer treatment. A new study finds that might need to be changed for certain leukemia patients.

There’s a reason it takes a brain surgeon to treat brain cancer. Both the organ and the disease are exceedingly complex. A new finding may offer new ways to treat this aggressive brain cancer.